The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nexi SpA
MIL:NEXI
|
IT |
|
Scandinavian Medical Solutions A/S
CSE:SMSMED
|
DK |
|
C
|
Centurion Finance ASI SA
WSE:CTF
|
PL |
|
AbL Diagnostics SA
PAR:ABLD
|
FR |
|
B
|
BG T&A Co
KOSDAQ:046310
|
KR |
|
Ko Gold Inc
OTC:KOGDF
|
CA |
|
D
|
Derwent London PLC
SWB:DVK
|
UK |
|
IFAST Corporation Ltd
F:1O3
|
SG |
|
U
|
Ultra Brands Ltd
CNSX:ULTA
|
CA |
|
B
|
Bodycote PLC
F:21T
|
UK |
|
Feintool International Holding AG
SIX:FTON
|
CH |
|
A
|
Alerio Gold Corp
OTC:ALEEF
|
CA |
|
W
|
Win Metals Ltd
OTC:WDGNF
|
AU |
|
F
|
Far East Orchard Ltd
XMUN:O5P
|
SG |
|
K
|
King Polytechnic Engineering Co Ltd
TPEX:6122
|
TW |
|
Dino Polska SA
F:5Y2
|
PL |
|
G
|
Guangzhou Grandbuy Co Ltd
SZSE:002187
|
CN |
|
P
|
Prothena Corporation PLC
F:0PT
|
IE |
|
A
|
Alpha Trust Holdings SA
ATHEX:ATRUST
|
GR |
|
Piche Resources Ltd
F:U8J
|
AU |
|
O
|
Optimi Health Corp
CNSX:OPTI
|
CA |
|
O
|
Orange Minerals NL
F:XO1
|
AU |
|
Red Cat Holdings Inc
NASDAQ:RCAT
|
PR |
|
Nomura Real Estate Holdings Inc
F:N9U
|
JP |
Nexi SpA (NEXI)’s 12-month stock price forecast through October 2027 has a consensus target of €4.08, implying 7% downside. The forecast is based on price targets from 18 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
NEXI is 4.08 EUR with a low forecast of 2.63 EUR and a high forecast of 6.3 EUR.
Over the last 8 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 7 years is -4%.
Over the last 8 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 3 years is -18%.
Over the last 8 years, the compound annual growth rate for Operating Income has been 22%. The projected CAGR for the next 5 years is 17%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more